AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 277: L49-L57, 1999;
1040-0605/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imaizumi, K.
Right arrow Articles by Hasegawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imaizumi, K.
Right arrow Articles by Hasegawa, Y.
Vol. 277, Issue 1, L49-L57, July 1999

Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction

Kazuyoshi Imaizumi1, Tsutomu Kawabe1, Satoshi Ichiyama2, Hitoshi Kikutani3, Hideo Yagita4, Kaoru Shimokata5, and Yoshinori Hasegawa1

1 The First Department of Internal Medicine and 5 Department of Clinical Preventive Medicine, Nagoya University School of Medicine, Nagoya 466-8550; 2 Department of Clinical Laboratory Medicine, Kyoto University Hospital, Kyoto 606-8507; 3 Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871; and 4 Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan

CD40-CD40 ligand (CD40L) interaction was originally defined as important molecules for the development of humoral immunity. Thereafter, some investigations have focused on its essential roles for the induction of cell-mediated immunity in host defenses. Here we investigated the antitumor activity of murine alveolar macrophages through CD40-CD40L interaction. The CD40L gene was transfected into murine lung cancer cells (3LLSA), and CD40L-expressing clones (3LLSA-CD40L) were established. Stimulation of CD40 molecules on the surface of alveolar macrophages with 3LLSA-CD40L cells induced the production of nitric oxide, tumor necrosis factor-alpha , and interleukin-12 and the tumoricidal activity of alveolar macrophages in the presence of interferon-gamma , which increased the surface expression of CD40 molecules on alveolar macrophages. These findings were not observed when alveolar macrophages were obtained from CD40-deficient mice. On the other hand, interleukin-6 production by alveolar macrophages did not depend on CD40-CD40L interaction. We also established a murine melanoma cell line expressing CD40L (B16 4A5-CD40L) that could induce tumoricidal activity of alveolar macrophages. Furthermore, when spleen cells were cocultivated with 3LLSA-CD40L cells, specific cytotoxic T lymphocytes for wild-type 3LLSA cells could be induced. These results suggest that CD40L gene transfer into tumor cells may induce antitumor immunity in a tumor-bearing host and may offer a new strategy for cancer gene therapy.

nitric oxide; cytokine production; cytotoxic T lymphocyte; lung cancer; CD40-deficient mice


This article has been cited by other articles:


Home page
BloodHome page
T. Kikuchi, M. Maemondo, K. Narumi, K. Matsumoto, T. Nakamura, and T. Nukiwa
Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells
Blood, December 1, 2002; 100(12): 3950 - 3959.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. N. Panjwani, L. Popova, and P. K. Srivastava
Heat Shock Proteins gp96 and hsp70 Activate the Release of Nitric Oxide by APCs
J. Immunol., March 15, 2002; 168(6): 2997 - 3003.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Barazzone Argiroffo, Y. R. Donati, J. Boccard, A. F. Rochat, C. Vesin, C.-D. Kan, and P.-F. Piguet
CD40-CD40 Ligand Disruption Does Not Prevent Hyperoxia-Induced Injury
Am. J. Pathol., January 1, 2002; 160(1): 67 - 71.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online